ABSTRACT
PURPOSE: The aim of this study is to evaluate the dosimetric performance of a newly developed proton-sensitive polymer gel formulation for proton therapy dosimetry. METHODS: Using passive scattered modulated and nonmodulated proton beams, the dose response of the gel was assessed. A next-generation optical CT scanner is used as the readout mechanism of the radiation-induced absorbance in the gel medium. Comparison of relative dose profiles in the gel to ion chamber profiles in water is performed. A simple and easily reproducible calibration protocol is established for routine gel batch calibrations. Relative stopping power ratio measurement of the gel medium was performed to ensure accurate water-equivalent depth dose scaling. Measured dose distributions in the gel were compared to treatment planning system for benchmark irradiations and quality of agreement is assessed using clinically relevant gamma index criteria. RESULTS: The dosimetric response of the gel was mapped up to 600 cGy using an electron-based calibration technique. Excellent dosimetric agreement is observed between ion chamber data and gel. The most notable result of this work is the fact that this gel has no observed dose quenching in the Bragg peak region. Quantitative dose distribution comparisons to treatment planning system calculations show that most (> 97%) of the gel dose maps pass the 3%/3 mm gamma criterion. CONCLUSIONS: This study shows that the new proton-sensitive gel dosimeter is capable of reproducing ion chamber dose data for modulated and nonmodulated Bragg peak beams with different clinical beam energies. The findings suggest that the gel dosimeter can be used as QA tool for millimeter range verification of proton beam deliveries in the dosimeter medium.
Subject(s)
Polymers/chemistry , Proton Therapy , Radiometry/methods , Calibration , Gels , Tomography, X-Ray ComputedABSTRACT
A proton beam delivery system on a gantry with continuous uniform scanning and dose layer stacking at the Midwest Proton Radiotherapy Institute has been commissioned and accepted for clinical use. This paper was motivated by a lack of guidance on the testing and characterization for clinical uniform scanning systems. As such, it describes how these tasks were performed with a uniform scanning beam delivery system. This paper reports the methods used and important dosimetric characteristics of radiation fields produced by the system. The commissioning data include the transverse and longitudinal dose distributions, penumbra, and absolute dose values. Using a 208 MeV cyclotron's proton beam, the system provides field sizes up to 20 and 30 cm in diameter for proton ranges in water up to 27 and 20 cm, respectively. The dose layer stacking method allows for the flexible construction of spread-out Bragg peaks with uniform modulation of up to 15 cm in water, at typical dose rates of 1-3 Gy/min. For measuring relative dose distributions, multielement ion chamber arrays, small-volume ion chambers, and radiographic films were employed. Measurements during the clinical commissioning of the system have shown that the lateral and longitudinal dose uniformity of 2.5% or better can be achieved for all clinically important field sizes and ranges. The measured transverse penumbra widths offer a slight improvement in comparison to those achieved with a double scattering beam spreading technique at the facility. Absolute dose measurements were done using calibrated ion chambers, thermoluminescent and alanine detectors. Dose intercomparisons conducted using various types of detectors traceable to a national standards laboratory indicate that the measured dosimetry data agree with each other within 5%.
Subject(s)
Proton Therapy , Radiation Dosage , Radiometry/methods , HumansABSTRACT
A percolation model of nuclear fragmentation is used to interpret 10.2 GeV/c p+197Au multifragmentation data. Emphasis is put on finding signatures of a continuous nuclear matter phase transition in finite nuclear systems. Based on model calculations, corrections accounting for physical constraints of the fragment detection and sequential decay processes are derived. Strong circumstantial evidence for a continuous phase transition is found, and the values of two critical exponents, sigma = 0.5+/-0.1 and tau = 2.35+/-0.05, are extracted from the data. A critical temperature of T(c) = 8.3+/-0.2 MeV is found.
ABSTRACT
The purpose of this study was to explore the potential advantages of using strong magnetic fields to increase tumor dose and to decrease normal tissue dose in radiation therapy. Strong magnetic fields are capable of altering the trajectories of charged particles. A magnetic field applied perpendicularly to the X-ray beam forces the secondary electrons and positrons to spiral and produces a dose peak. The same magnetic field also prevents the electrons and positrons from traveling downstream and produces a lower dose region distal to the dose peak. The locations of these high- and low-dose regions are potentially adjustable to enhance the dose to the target volume and decrease the dose to normal tissues. We studied this effect using the Monte Carlo simulation technique. The EGS4 code was used to simulate the effect produced by a coil magnet currently under construction. The coil magnet is designed to support up to 350 A operating current and 15 T peak field on windings. Dose calculations in a water phantom show that the transverse magnetic field produces significant dose effects along the beam direction of radiation therapy X-rays. Depending on the beam orientation, the radiation dose at different depths along the beam can be increased or reduced. This dose effect varies with photon energy, field size, magnetic field strength, and relative magnet/beam geometry. The off-axis beam profiles also show considerable skewness under the influence of the magnetic field. The magnetic field-induced dose shift may result in high dose regions outside the geometrical boundary of the initial radiation beam. We have demonstrated that current or near-term magnet technology is capable of producing significant dose enhancement and reduction in radiation therapy photon beams. This technology should be further developed to improve our ability to deliver higher doses to the tumor and lower doses to normal tissues in radiation therapy.
Subject(s)
Electromagnetic Fields , Radiotherapy/methods , Humans , Monte Carlo Method , Photons , Radiotherapy Planning, Computer-AssistedABSTRACT
The evolution of the beam distribution in a double-rf system with a phase modulation on either the primary or secondary rf cavity was measured. We find that the particle diffusion process obeys the Einstein relation if the phase space becomes globally chaotic. When dominant parametric resonances still exist in the phase space, particles stream along the separatrices of the dominant resonance, and the beam width exhibits characteristic oscillatory structure. The particle-tracking simulations for the double-rf system are employed to reveal the essential diffusion mechanism. Coherent octupolar motion has been observed in the bunch beam excitation. The evolution of the longitudinal phase space in the octupole mode is displayed.